Search Results 2091-2100 of 19660 for hemoglobin

  1. A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL;; PT/INR, aPTT ≤ 1.5 x ULN unless participant is receiving a stable dose of therapeutic anticoagulation;; Albumin ≥ 3.0 g/dL ...

  2. Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma - Mayo Clinic

    Hemoglobin < 8 g/dL (< 4.9 mmol/L) (transfusion is not permitted within 21 days of screening);; Creatinine clearance (CrCl) as reported below;; Corrected ...

  3. Orthopedic Surgery - Clinical trials

    ... hemoglobin levels, 90-day complications, readmission and reoperation. Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With ...

  4. Oral AMXT 1501 Dicaprate in Combination With IV DFMO - Mayo Clinic

    Hemoglobin ≥ 9 g/dL, without transfusion support within 7 days preceding the lab assessment;; Activated partial thromboplastin time/ partial thromboplastin ...

  5. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

    Hemoglobin ≥ 8 g/dL or ≥ 5.6 mmol/L. Platelets ≥ 100 x10^9 /L (not achieved by transfusion). Creatinine clearance ≥ 40 mL/min. Participants who are ...

  6. A Randomized Phase III Trial of Eribulin Compared to Standard Weekly Paclitaxel as First- or Second-Line Therapy for Locally Recurrent or Metastatic Breast Cancer - Mayo Clinic

    Obtained =< 7 days prior to registration: Hemoglobin >= 9 g/dL;; Obtained =< 7 days prior to registration: Total bilirubin =< 1.5 times the upper limit of ...

  7. Special Report

    A1C test — This test, also known as the glycated hemoglobin test, measures the percentage of glucose that's attached to hemoglobin, a protein in red blood cells ...

  8. A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma - Mayo Clinic

    * For patients with solid tumors: Hemoglobin >= 8.0 g/dL (may receive red blood cell [RBC] transfusions) (Must be performed within 7 days prior to ...

  9. A Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS) - Mayo Clinic

    A hemoglobin (Hb) concentration \<11.0 grams per deciliter (g/dL) during the 4-week Screening Period; 5. Eastern Cooperative Oncology Group (ECOG) ...

  10. Study of BIIB092 in Participants With Progressive Supranuclear Palsy - Mayo Clinic

    Hemoglobin A1C (HbA1C) > 8%, confirmed by repeat. Allergies and Adverse Drug Reaction. History of allergy, hypersensitivity, or serious adverse reaction to ...